283 related articles for article (PubMed ID: 30384188)
1. Rapid bioanalytical LC-MS/MS method for the simultaneous determination of sofosbuvir and velpatasvir in human plasma-application to a pharmacokinetic study in Egyptian volunteers.
Elkady EF; Aboelwafa AA
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Dec; 1102-1103():116-124. PubMed ID: 30384188
[TBL] [Abstract][Full Text] [Related]
2. Novel determination of sofosbuvir and velpatasvir in human plasma by UPLC-MS/MS method: Application to a bioequivalence study.
Rezk MR; Basalious EB; Badr KA
Biomed Chromatogr; 2018 Nov; 32(11):e4347. PubMed ID: 30047564
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of LC-MS/MS method for simultaneous determination of sofosbuvir and daclatasvir in human Plasma: Application to pharmacokinetic study.
Abdallah OM; Abdel-Megied AM; Gouda AS
Biomed Chromatogr; 2018 Jun; 32(6):e4186. PubMed ID: 29314090
[TBL] [Abstract][Full Text] [Related]
4. A Rapid and Optimized LC-MS/MS Method for the Simultaneous Extraction and Determination of Sofosbuvir and Ledipasvir in Human Plasma.
Elkady EF; Aboelwafa AA
J AOAC Int; 2016 Sep; 99(5):1252-9. PubMed ID: 27480956
[TBL] [Abstract][Full Text] [Related]
5. Development a validated highly sensitive LC-MS/MS method for simultaneous quantification of Ledipasvir, sofosbuvir and its major metabolite GS-331007 in human plasma: Application to a human pharmacokinetic study.
Abdallah OM; Abdel-Megied AM; Gouda AS
J Pharm Biomed Anal; 2017 Sep; 143():305-310. PubMed ID: 28645021
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous determination of ledipasvir, sofosbuvir and its metabolite in rat plasma by UPLC-MS/MS and its application to a pharmacokinetic study.
Pan C; Chen Y; Chen W; Zhou G; Jin L; Zheng Y; Lin W; Pan Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan; 1008():255-259. PubMed ID: 26684720
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a stability-Indicating RP-HPLC method for simultaneous estimation of sofosbuvir and velpatasvir in fixed dose combination tablets and plasma.
Mehmood Y; Khan IU; Shahzad Y; Khalid SH; Irfan M; Asghar S; Yousaf AM; Hussain T; Khalid I
Pak J Pharm Sci; 2019 Jul; 32(4(Supplementary)):1835-1842. PubMed ID: 31680080
[TBL] [Abstract][Full Text] [Related]
8. Quantification of sofosbuvir and ledipasvir in human plasma by UPLC-MS/MS method: Application to fasting and fed bioequivalence studies.
Rezk MR; Bendas ER; Basalious EB; Karim IA
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1028():63-70. PubMed ID: 27322631
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, Safety, and Tolerability of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir in Healthy Chinese Subjects.
Li C; Li X; Zhu X; Zhang H; Shen G; Kersey K; Ding Y
Clin Ther; 2020 Mar; 42(3):448-457. PubMed ID: 32115243
[TBL] [Abstract][Full Text] [Related]
10. Validated LC-MS-MS Method for Determination of SF0034 in Mice Plasma: Application to a Pharmacokinetic Study in Mice.
Todmal U; Suresh PS; Zainuddin M; Kanth Bhamidipati R; Samanta SK; Hallur G; Rajagopal S; Rajagopal S; Mullangi R
J Chromatogr Sci; 2017 Aug; 55(7):750-756. PubMed ID: 28383683
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of LC-MS/MS method for quantification of bictegravir in human plasma and its application to an intracellular uptake study.
Prathipati PK; Mandal S; Destache CJ
Biomed Chromatogr; 2019 Feb; 33(2):e4379. PubMed ID: 30178512
[TBL] [Abstract][Full Text] [Related]
12. Novel and sensitive UPLC-MS/MS method for quantification of sofosbuvir in human plasma: application to a bioequivalence study.
Rezk MR; Basalious EB; Amin ME
Biomed Chromatogr; 2016 Sep; 30(9):1354-62. PubMed ID: 26821881
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a new HPLC-DAD method for quantification of sofosbuvir in human serum and its comparison with LC-MS/MS technique: Application to a bioequivalence study.
Miraghaei S; Mohammadi B; Babaei A; Keshavarz S; Bahrami G
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1063():118-122. PubMed ID: 28858753
[TBL] [Abstract][Full Text] [Related]
14. Quick and Sensitive UPLC-ESI-MS/MS Method for Simultaneous Estimation of Sofosbuvir and Its Metabolite in Human Plasma.
Semreen MH; Alniss HY; Mousa MK; Aboul-Enein HY
Molecules; 2019 Apr; 24(7):. PubMed ID: 30987096
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of liquid chromatography-electrospray-tandem mass spectrometry method for determination of flibanserin in human plasma: Application to pharmacokinetic study on healthy female volunteers.
Sultan MA; El-Eryan RT; Attia AK; Eissa MJ
Biomed Chromatogr; 2019 Aug; 33(8):e4545. PubMed ID: 30937940
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC-MS/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin/naloxone formulation.
Moreno-Vicente R; Fernández-Nieva Z; Navarro A; Gascón-Crespí I; Farré-Albaladejo M; Igartua M; Hernández RM; Pedraz JL
J Pharm Biomed Anal; 2015 Oct; 114():105-12. PubMed ID: 26037158
[TBL] [Abstract][Full Text] [Related]
17. A liquid chromatography-tandem mass spectrometry method for simultaneous determination of simeprevir, daclatasvir, sofosbuvir, and GS-331007 applied to a retrospective clinical pharmacological study.
Ferrari D; Bagaglio S; Raso M; Galli L; Premaschi S; Messina E; Morsica G; Locatelli M; Uberti-Foppa C; Hasson H
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jul; 1120():1-7. PubMed ID: 31055190
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of High-Throughput Bioanalytical Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Newly Synthesized Antitumor Carbonic Anhydrase Inhibitors in Human Plasma.
Abdel-Megied AM; Eldehna WM; Abdelrahman MA; Elbarbry FA
Molecules; 2020 Dec; 25(23):. PubMed ID: 33291270
[TBL] [Abstract][Full Text] [Related]
19. Development of a sensitive UPLC-ESI-MS/MS method for quantification of sofosbuvir and its metabolite, GS-331007, in human plasma: Application to a bioequivalence study.
Rezk MR; Basalious EB; Karim IA
J Pharm Biomed Anal; 2015 Oct; 114():97-104. PubMed ID: 26037157
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a rapid method for the simultaneous quantification of ribavirin, sofosbuvir and its metabolite in rat plasma by UPLC-MS/MS.
Shi X; Zhu D; Lou J; Zhu B; Hu AR; Gan D
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Oct; 1002():353-7. PubMed ID: 26363369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
